LOreal Paris Visible Lift description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

LOreal Paris Visible Lift

L'Oreal USA Products Inc

Drug Facts


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Active ingredients

Octinoxate 7.5%

Titanium dioxide 8.9%

Directions

Apply before sun exposure.

Warnings

FOR EXTERNAL USE ONLY. AVOID CONTACT WITH EYES.DISCONTINUE USE IF SIGNS OF IRRITATION OR RASH APPEAR.KEEP OUT  OF REACH OF CHILDREN.

Inactive ingredients

WATER, CYCLOPENTASILOXANE, PHENYL TRIMETHICONE, CYCLOHEXASILOXANE, BUTYLENE GLYCOL, CETYL PEG/PPG-10/1 DIMETHICONE, PENTYLENE GLYCOL, POLYGLYCERYL-4 ISOSTEARATE, PHENOXYETHANOL, MAGNESIUM SULFATE, PEG-10 DIMETHICONE, CELLULOSE GUM, SORBITOL, DISODIUM STEAROYL GLUTAMATE, METHYLPARABEN, PEG/PPG-18/18 DIMETHICONE, ACRYLATES COPOLYMER, TOCOPHEROL, METHYLSILANOL/SILICATE CROSSPOLYMER, PENTAERYTHRITYL TETRAISOSTEARATE, ALUMINUM HYDROXIDE, RETINYL PALMITATE, HYDROLYZED ELASTIN, SILICA DIMETHYL SILYLATE, POLYCAPROLACTONE, SODIUM CHONDROITIN SULFATE, ATELOCOLLAGEN; MAY CONTAIN: TITANIUM DIOXIDE, IRON OXIDES, BISMUTH OXYCHLORIDE

LOreal Paris Visible Lift

LOreal Paris Visible Lift

Octinoxate Titanium Dioxide LIQUID

Product Information

Product Type Human otc drug label Item Code (Source) NDC:49967-844
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 1.375 mL
titanium dioxide 2.225 mL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49967-844-01 25 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2011-04-15


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.